{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T05:19:48Z","timestamp":1791091188258,"version":"4.1.0"},"reference-count":34,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2011,8,11]],"date-time":"2011-08-11T00:00:00Z","timestamp":1313020800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0022854","type":"journal-article","created":{"date-parts":[[2011,8,11]],"date-time":"2011-08-11T22:55:40Z","timestamp":1313103340000},"page":"e22854","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":66,"title":["Serum Cholesterol and the Progression of Parkinson's Disease: Results from DATATOP"],"prefix":"10.1371","volume":"6","author":[{"given":"Xuemei","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peggy","family":"Auinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirley","family":"Eberly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Oakes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Schwarzschild","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Ascherio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Mailman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honglei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the Parkinson Study Group DATATOP Investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2011,8,11]]},"reference":[{"key":"ref1","first-page":"90","article-title":"Etiology of Parkinson&apos;s Disease,","author":"CM Tanner","year":"2002"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/mds.21290","article-title":"Lower LDL cholesterol levels are associated with Parkinson&apos;s disease: a case control study.","volume":"22","author":"X Huang","year":"2007","journal-title":"Mov Disord"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1161\/01.STR.0000217384.03237.9c","article-title":"Reduced risk factors for vascular disorders in Parkinson disease patients: a case-control study.","volume":"37","author":"G Scigliano","year":"2006","journal-title":"Stroke"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jns.2010.03.002","article-title":"Case-control study of risk of Parkinson&apos;s disease in relation to hypertension, hypercholesterolemia, and diabetes in Japan.","volume":"293","author":"Y Miyake","year":"2010","journal-title":"J Neurol Sci"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1002\/mds.22013","article-title":"Low LDL cholesterol and increased risk of Parkinson&apos;s disease: prospective results from Honolulu-Asia Aging Study.","volume":"23","author":"X Huang","year":"2008","journal-title":"Mov Disord"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1093\/aje\/kwj283","article-title":"Serum Cholesterol Levels and the Risk of Parkinson&apos;s Disease.","volume":"164","author":"LM de Lau","year":"2006","journal-title":"Am J Epidemiol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1212\/01.wnl.0000271883.45010.8a","article-title":"Hypertension, hypercholesterolemia, diabetes, and risk of Parkinson disease.","volume":"69","author":"KC Simon","year":"2007","journal-title":"Neurology"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1212\/01.wnl.0000312511.62699.a8","article-title":"Total cholesterol and the risk of Parkinson disease.","volume":"70","author":"G Hu","year":"2008","journal-title":"Neurology"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1056\/NEJM198911163212004","article-title":"Effect of deprenyl on the progression of disability in early Parkinson&apos;s disease. The Parkinson Study Group.","volume":"321","year":"1989","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1016\/S0149-2918(03)80134-0","article-title":"The relationship between nonfasting and fasting lipid measurements in patients with or without type 2 diabetes mellitus receiving treatment with 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors.","volume":"25","author":"R Weiss","year":"2003","journal-title":"Clin Ther"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1212\/01.WNL.0000148603.44618.19","article-title":"Survival in Parkinson disease: thirteen-year follow-up of the DATATOP cohort.","volume":"64","author":"C Marras","year":"2005","journal-title":"Neurology"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1212\/WNL.56.12.1712","article-title":"Freezing of gait in PD: prospective assessment in the DATATOP cohort.","volume":"56","author":"N Giladi","year":"2001","journal-title":"Neurology"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1001\/archneur.2008.65.6.nct70003","article-title":"Serum urate as a predictor of clinical and radiographic progression in Parkinson disease.","volume":"65","author":"MA Schwarzschild","year":"2008","journal-title":"Arch Neurol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1212\/WNL.40.10.1529","article-title":"Variable expression of Parkinson&apos;s disease: a base-line analysis of the DATATOP cohort. The Parkinson Study Group.","volume":"40","author":"J Jankovic","year":"1990","journal-title":"Neurology"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S0022-2275(20)39173-2","article-title":"Effects of age, gender, and menopausal status on plasma low density lipoprotein cholesterol and apolipoprotein B levels in the Framingham Offspring Study.","volume":"35","author":"EJ Schaefer","year":"1994","journal-title":"J Lipid Res"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1001\/archneur.59.10.1541","article-title":"Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline.","volume":"59","author":"CW Shults","year":"2002","journal-title":"Arch Neurol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"414, 417","DOI":"10.1001\/archinte.1992.00400140150034","article-title":"Lowering cholesterol and death due to accidents, suicides: unresolved issues.","volume":"152","author":"RS Vasan","year":"1992","journal-title":"Arch Intern Med"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/j.1600-0447.1994.tb01589.x","article-title":"Lower degree of esterification of serum cholesterol in depression: relevance for depression and suicide research.","volume":"90","author":"M Maes","year":"1994","journal-title":"Acta Psychiatr Scand"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1126\/science.1066724","article-title":"Neurobiology. Cholesterol\u2013making or breaking the synapse.","volume":"294","author":"BA Barres","year":"2001","journal-title":"Science"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/71366","article-title":"Cholesterol binds to synaptophysin and is required for biogenesis of synaptic vesicles.","volume":"2","author":"C Thiele","year":"2000","journal-title":"Nat Cell Biol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1093\/emboj\/20.9.2202","article-title":"SNAREs are concentrated in cholesterol-dependent clusters that define docking and fusion sites for exocytosis.","volume":"20","author":"T Lang","year":"2001","journal-title":"EMBO J"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1523\/JNEUROSCI.21-02-00504.2001","article-title":"Membrane lipid rafts are necessary for the maintenance of the (alpha)7 nicotinic acetylcholine receptor in somatic spines of ciliary neurons.","volume":"21","author":"JL Bruses","year":"2001","journal-title":"J Neurosci"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1530\/eje.0.1450669","article-title":"Neurosteroid metabolism in the human brain.","volume":"145","author":"B Stoffel-Wagner","year":"2001","journal-title":"Eur J Endocrinol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1046\/j.1460-9568.2002.02084.x","article-title":"The neurosteroid allopregnanolone increases dopamine release and dopaminergic response to morphine in the rat nucleus accumbens.","volume":"16","author":"F Rouge-Pont","year":"2002","journal-title":"Eur J Neurosci"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"3757","DOI":"10.1046\/j.1460-9568.1999.00816.x","article-title":"The neurosteroid pregnenolone sulphate increases dopamine release and the dopaminergic response to morphine in the rat nucleus accumbens.","volume":"11","author":"M Barrot","year":"1999","journal-title":"Eur J Neurosci"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/S0278-5846(00)00124-X","article-title":"Neuroprotective effects of allopregnenolone on hippocampal irreversible neurotoxicity in vitro.","volume":"24","author":"C Frank","year":"2000","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1212\/01.wnl.0000285080.70324.27","article-title":"Dyslipidemia is a protective factor in amyotrophic lateral sclerosis.","volume":"70","author":"L Dupuis","year":"2008","journal-title":"Neurology"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1002\/mds.22459","article-title":"Serum cholesterol levels and the risk of multiple system atrophy: a case-control study.","volume":"24","author":"PH Lee","year":"2009","journal-title":"Mov Disord"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1001\/jama.282.24.2340","article-title":"Effect of statins on risk of coronary disease: a meta-analysis of randomized controlled trials.","volume":"282","author":"JC LaRosa","year":"1999","journal-title":"JAMA"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1001\/archinte.164.13.1427","article-title":"Effectiveness of statin therapy in adults with coronary heart disease.","volume":"164","author":"TJ Wilt","year":"2004","journal-title":"Arch Intern Med"},{"key":"ref31","first-page":"561","article-title":"Neuroprotective properties of statins.","volume":"57","author":"K Stepien","year":"2005","journal-title":"Pharmacol Rep"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1111\/j.1471-4159.2008.05254.x","article-title":"Statins reduce neuronal alpha-synuclein aggregation in in vitro models of Parkinson&apos;s disease.","volume":"105","author":"P Bar-On","year":"2008","journal-title":"J Neurochem"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"23622","DOI":"10.1074\/jbc.M313784200","article-title":"Beta-synuclein regulates Akt activity in neuronal cells. A possible mechanism for neuroprotection in Parkinson&apos;s disease.","volume":"279","author":"M Hashimoto","year":"2004","journal-title":"J Biol Chem"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1212\/01.wnl.0000277648.63931.c0","article-title":"Mixed lineage kinase inhibitor CEP-1347 fails to delay disability in early Parkinson disease.","volume":"69","year":"2007","journal-title":"Neurology"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0022854","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T07:34:37Z","timestamp":1638257677000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0022854"}},"subtitle":[],"editor":[{"given":"Colin","family":"Combs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2011,8,11]]},"references-count":34,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2011,8,11]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0022854","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,8,11]]}}}